IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
Business Wire•07/10/2026•16:15 ET
0
Key Highlights
- ➤IQVIA launched Life Science Models to predict clinical trial outcomes.
- ➤85% of predictions were on target or clinically close across 50 trials and 270 endpoints.
- ➤Models support study simulation, protocol optimization, digital twins and synthetic controls.
- ➤NVIDIA Nemotron and AWS infrastructure support the new life sciences models.
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Life Science Models(TM) to help predict clinical trial outcomes.
Get started
Create a free account to read the full story.